Abstract
Background: β-caryophyllene (BCP) is a natural bicyclic sesquiterpene found in Ccannabis and other plants. BCP is currently used as a food additive, although pharmacological studies suggest its potential therapeutic application for the treatment of certain brain disorders. The mechanisms of action of BCP remain uncertain, possibly including full agonism at the cannabinoid CB 2 receptor (CB 2 R).
Objective: The study aims to investigate the BCP’s potential as a new drug for the treatment of substance use disorders, by reviewing preclinical studies with animal models.
Results: BCP has been investigated in behavioral paradigms, including drug self-administration, conditioned place preference, and intracranial self-stimulation; the drugs tested were cocaine, nicotine, alcohol, and methamphetamine. Remarkably, BCP prevented or reversed behavioral changes resulting from drug exposure. As expected, the mechanism of action entails CB 2 R activation, although this is unlikely to constitute the only molecular target to explain such effects. Another potential target is the peroxisome proliferator-activated receptor.
Conclusion: Preclinical studies report promising results with BCP in animal models of substance use disorders. Further research, including studies in humans, are warranted to establish its therapeutic potential and its mechanisms of action.
Keywords: Abuse, Addiction, Cannabinoids, Cannabis, Drugs, β-caryophyllene
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder.Neuropsychopharmacology. 2021 Mar;46(4):860-870. doi: 10.1038/s41386-020-00885-4. Epub 2020 Oct 17.PMID: 33069159 Free PMC article.
-
β-Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents.Br J Pharmacol. 2020 May;177(9):2058-2072. doi: 10.1111/bph.14969. Epub 2020 Feb 15.PMID: 31883107 Free PMC article.
-
β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms.Front Pharmacol. 2021 Sep 9;12:722476. doi: 10.3389/fphar.2021.722476. eCollection 2021.PMID: 34566647 Free PMC article.
-
A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid.Biomed Pharmacother. 2021 Aug;140:111639. doi: 10.1016/j.biopha.2021.111639. Epub 2021 Jun 3.PMID: 34091179 Review.
-
β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and analgesic properties.Cancer Med. 2016 Oct;5(10):3007-3017. doi: 10.1002/cam4.816. Epub 2016 Sep 30.PMID: 27696789 Free PMC article. Review.
LinkOut – more resources
-
Full Text Sources
-
Research Materials